Bioinformatics analysis and in vivo and vitro modeling indicated that the EFNB2/EPHB4 axis upregulated the expression of LDLR, but not that of the synthetic genes of cholesterol in CRC LM. This evidence concerns the gene EPHB4 and colorectal carcinoma.